IPO
Atreca
Biopharmaceutical
We are a biopharmaceutical company utilizing our differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types.
Symbol
BCEL
Price Range
$16.00 - $18.00
Anticipated Date
June 20, 2019
Underwriters
COWEN AND COMPANY, LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Atreca IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277